Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search
Phenotype

Lung cancer

398articles
398mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Identification of novel peptide inhibitors for oncogenic KRAS G12D as therapeutic options using mutagenesis-based remodeling and MD simulations.

PMID 37010994 | DOI 10.1080/07391102.2023.2192298 · Journal of biomolecular structure & dynamics · 2023 · 5 validated mentions
TypeEntitySource evidenceConfidenceExtractor
phenotypelung cancer“Among all the mutations in exon 12 and exon 13 of the KRAS gene, the G12D mutation is more prevalent in pancreatic and lung cancer and accounts for around 41% of all G12 mutations, making them potential anticancer therapeutic targets.”0.98phenotype_alias_lexicon_v2
variantG12D“Among all the mutations in exon 12 and exon 13 of the KRAS gene, the G12D mutation is more prevalent in pancreatic and lung cancer and accounts for around 41% of all G12 mutations, making them potential anticancer therapeutic targets.”0.82literature_variant_regex_v2
geneKRAS“Identification of novel peptide inhibitors for oncogenic KRAS G12D as therapeutic options using mutagenesis-based remodeling and MD simulations.”0.98hgnc_dict_v1
geneHRAS“Human malignancies typically show mutations in the Ras gene including HRAS, KRAS, and NRAS.”0.98hgnc_dict_v1